Cargando…

Elective Hand Surgery in Patients With History of Axillary Node Dissection: Risks and Patient Education

Objective: To determine if patients with a prior history of axillary lymph node dissection (ALND) secondary to breast cancer surgery and other procedures are at an increased risk of postoperative complications including lymphedema and infection following elective upper extremity surgery. Furthermore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awan, Muhammad Usman, Schwartz, Gary, Shifchik, Anastassia, Harmon, Skylar, Malisetyan, Tatevik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420452/ https://www.ncbi.nlm.nih.gov/pubmed/36051709 http://dx.doi.org/10.7759/cureus.27461

Ejemplares similares

A Critical Examination of Antibiotic Administration in Septorhinoplasty and Endoscopic Sinus Surgery: A Systematic Review
por: Benites, Cristina, et al.
Publicado: (2023)

Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017)

Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15 Years of Follow-Up
por: Martelli, Gabriele, et al.
Publicado: (2010)

Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
por: Yuan, Qianqian, et al.
Publicado: (2021)

Can targeted axillary dissection reliably advise de-escalation of completion axillary lymph node dissection?
por: Owusu-Brackett, Nicci, et al.
Publicado: (2023)

Could axillary lymph node dissection be omitted in the mastectomy patient with tumor positive sentinel node?
por: You, Ji Young, et al.
Publicado: (2023)

Axillary lymph node dissection: Dead or still alive?
por: Beck, Anna C., et al.
Publicado: (2023)

Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Kristen, P, et al.
Publicado: (2005)

Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients
por: Soares, Emerson Wander Silva, et al.
Publicado: (2014)

Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node
por: Houvenaeghel, Gilles, et al.
Publicado: (2018)

Sentinel node biopsy versus conventional axillary dissection in clinically node-negative breast cancer patients
por: Bear, HD
Publicado: (2005)

Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy
por: Bukovszky, Bence, et al.
Publicado: (2022)

Reply: Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Reitsamer, R, et al.
Publicado: (2005)

Can axillary radiotherapy replace axillary dissection for patients with positive sentinel nodes? A systematic review and meta-analysis
por: Zhao, Min, et al.
Publicado: (2017)

Axillary Reverse Mapping in Patients Undergoing Axillary Lymph Node Dissection: A Single Institution Experience From India
por: Jena, Sanghamitra, et al.
Publicado: (2021)

Dissection of Level III Axillary Lymph Nodes in Breast Cancer
por: Hu, Jiejie, et al.
Publicado: (2021)

Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer
por: Weber, Walter P., et al.
Publicado: (2023)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

Vascularized Free Lymph Node Flap Transfer in Advanced Lymphedema Patient after Axillary Lymph Node Dissection
por: Cook, Kyung Hoon, et al.
Publicado: (2016)

The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)

Axillary lymph node dissection for breast cancer utilizing Harmonic Focus(®)
por: Ostapoff, Katherine T, et al.
Publicado: (2011)

Idiopathic Thrombocytopenic Purpura after Mastectomy and Axillary Lymph Node Dissection
por: Santivasi, Wil L., et al.
Publicado: (2014)

Axillary Lymph Node Dissection in Angiosarcomas of the Breast: An Asian Institutional Perspective
por: Ragavan, Sharanniyan, et al.
Publicado: (2020)

Evaluation of the impact of the COVID-19 pandemic on the practice of axillary node dissection
por: Harris, G.A., et al.
Publicado: (2021)

Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis
por: Fan, Yu-Jia, et al.
Publicado: (2023)

Contrast of Mastoscopic and Conventional Axillary Lymph Node Dissection of Patients With Breast Cancer: Meta-Analysis
por: Xiong, Hanchu, et al.
Publicado: (2020)

Chyle Leak after Right Axillary Lymph Node Dissection in a Patient with Breast Cancer
por: Sarawagi, Ankita, et al.
Publicado: (2021)

Survival and recurrence with or without axillary dissection in patients with invasive breast cancer and sentinel node metastasis
por: Sanvido, Vanessa Monteiro, et al.
Publicado: (2021)

Same‐day mastectomy and axillary lymph node dissection is safe for most patients with breast cancer
por: Tamminen, Anselm, et al.
Publicado: (2022)

Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases
por: Lee, Jina, et al.
Publicado: (2018)

Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes
por: Kim, Bong Kyun, et al.
Publicado: (2020)

Comparison of indocyanine green and methylene blue use for axillary reverse mapping during axillary lymph node dissection
por: Wu, Jun‐Dong, et al.
Publicado: (2020)

200 Sentinel lymph node biopsies without axillary lymph node dissection – no axillary recurrences after a 3-year follow-up
por: Reitsamer, R, et al.
Publicado: (2004)

Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer
por: Li, Jianyi, et al.
Publicado: (2015)

Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis?
por: Damle, Sameer, et al.
Publicado: (2009)

Postmastectomy/Axillary Node Dissection Chyloma: The Additional Value of SPECT/CT Lymphoscintigraphy
por: Thang, Sue Ping, et al.
Publicado: (2014)

Axillary Lymph Node Dissection for Breast Cancer: Efficacy and Complication in Developing Countries
por: Abass, Mohaned O., et al.
Publicado: (2018)

Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?
por: Gebhardt, Brian J., et al.
Publicado: (2018)

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
por: de Boniface, Jana, et al.
Publicado: (2017)

Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
por: Sarri, Almir José, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f9qi4v2vb4tf3ol598t86cegep